# Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS

> **NCT02546817** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 29 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02546817
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-30
- **Primary completion:** 2017-09-29
- **Final completion:** 2017-09-29
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2017-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02546817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02546817, "Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02546817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*